Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Wednesday, November 11, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
A “Living Medicine:” Engineered E. coli Shrink Tumors in Mice
Ogkologos
-
December 11, 2024
0
EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma
Ogkologos
-
December 11, 2024
0
FDA Approves Revumenib for Relapsed or Refractory Acute Leukaemia with a...
Ogkologos
-
December 10, 2024
0
Nivolumab plus Ipilimumab Improves PFS Over Chemotherapy Among Previously Untreated Patients...
Ogkologos
-
December 9, 2024
0
Significant OS Benefit with Glofitamab plus GemOx in Transplant-Ineligible Patients with...
Ogkologos
-
December 6, 2024
0
Treatment Strategy for ecDNA-Driven Tumors Shows Potential
Ogkologos
-
December 5, 2024
0
Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with...
Ogkologos
-
December 5, 2024
0
EMA Recommends Granting a Marketing Authorisation for Lazertinib
Ogkologos
-
December 4, 2024
0
FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell...
Ogkologos
-
December 3, 2024
0
ESMO Immuno-Oncology Congress 2024, Geneva, Switzerland, 11-13 December
Ogkologos
-
December 2, 2024
0
1
...
62
63
64
...
440
Page 63 of 440
MOST POPULAR
Patients with Advanced Hodgkin’s Lymphoma Treated with Brentuximab Vedotin Plus AVD...
July 19, 2022
Teclistamab Shows Promise for People with Heavily Pretreated Multiple Myeloma
September 29, 2022
Making the most of your ‘eureka’ moment: getting from the science...
September 22, 2021
Ex-NFL Player Pays For 500 Mammograms To Honor Late Mom Who...
October 22, 2019
Load more
HOT NEWS
Tarlatamab Prolongs OS Over Chemotherapy Among Patients with SCLC Whose Disease...
ΚΑΡΚΙΝΟΣ ΤΟΥ ΜΑΣΤΟΥ
Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL
Why people and culture matter in research
Ελληνικά
English (UK)
